Heart failure in general and cardiac transplant patients with COVID-19

作     者：Munish Sharma Gowthami Sai Kogilathota Jagirdhar Kalpalatha K Guntupalli Rahul Kashyap Salim Surani 

作者机构：Department of MedicineBaylor College of MedicineHoustonTX 77030United States Department of MedicineSt Michaels'Medical CenterNewarkNJ 07102United States Department of PulmonaryCritical Care and SleepBaylor College of MedicineHoustonTX 77030United States Department of AnesthesiologyMayo ClinicRochesterMN 55905United States Department of MedicineTexas A&M UniversityBryanTX 77807United States 

出 版 物：《World Journal of Cardiology》 (世界心脏病学杂志（英文版）（电子版）)

年 卷 期：2022年第14卷第7期

页      面：392-402页

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：COVID-19 Coronavirus Cardiomyopathy Heart failure Cardiomyopathy 

摘      要：Coronavirus disease 2019(COVID-19)is primarily an infection of the respiratory tract,but it can have multisystem *** complications of COVID-19 can range from acute myocardial injury,cardiac arrhythmias,or heart failure,amongst *** failure(HF)in COVID-19 can be a de novo process or due to worsening of pre-existing cardiovascular *** in a patient with COVID-19 not only poses challenges in clinical presentation and management of COVID-19 but also affect prognosis of the *** article aims to succinctly revisit the implications of this pandemic regarding pre-existing HF or new-onset HF based on prevailing *** also focuses on the management and special recommendations from prior studies and guidelines.